116 related articles for article (PubMed ID: 28837806)
1. Rhodospirillum rubruml-asparaginase targets tumor growth by a dual mechanism involving telomerase inhibition.
Zhdanov DD; Pokrovsky VS; Pokrovskaya MV; Alexandrova SS; Eldarov MA; Grishin DV; Basharov MM; Gladilina YA; Podobed OV; Sokolov NN
Biochem Biophys Res Commun; 2017 Oct; 492(2):282-288. PubMed ID: 28837806
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of telomerase activity and induction of apoptosis by Rhodospirillum rubrum L-asparaginase in cancer Jurkat cell line and normal human CD4+ T lymphocytes.
Zhdanov DD; Pokrovsky VS; Pokrovskaya MV; Alexandrova SS; Eldarov MA; Grishin DV; Basharov MM; Gladilina YA; Podobed OV; Sokolov NN
Cancer Med; 2017 Nov; 6(11):2697-2712. PubMed ID: 28984046
[TBL] [Abstract][Full Text] [Related]
3. [Suppression of telomerase activity leukemic cells by mutant forms of Rhodospirillum rubrum L-asparaginase].
Pokrovskaya MV; Zhdanov DD; Eldarov MA; Aleksandrova SS; Veselovskiy AV; Pokrovskiy VS; Grishin DV; Gladilina JA; Sokolov NN
Biomed Khim; 2017 Jan; 63(1):62-74. PubMed ID: 28251953
[TBL] [Abstract][Full Text] [Related]
4. Identification of functional regions in the Rhodospirillum rubrum L-asparaginase by site-directed mutagenesis.
Pokrovskaya MV; Aleksandrova SS; Pokrovsky VS; Veselovsky AV; Grishin DV; Abakumova OY; Podobed OV; Mishin AA; Zhdanov DD; Sokolov NN
Mol Biotechnol; 2015 Mar; 57(3):251-64. PubMed ID: 25370827
[TBL] [Abstract][Full Text] [Related]
5. Penetration into Cancer Cells via Clathrin-Dependent Mechanism Allows L-Asparaginase from
Plyasova AA; Pokrovskaya MV; Lisitsyna OM; Pokrovsky VS; Alexandrova SS; Hilal A; Sokolov NN; Zhdanov DD
Pharmaceuticals (Basel); 2020 Sep; 13(10):. PubMed ID: 33008089
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
Rao Y; Xiong W; Liu H; Jia C; Zhang H; Cui Z; Zhang Y; Cui J
Breast Cancer; 2016 Mar; 23(2):216-23. PubMed ID: 25098685
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
8. [Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes].
Zhdanov DD; Vasina DА; Orlova EV; Orlova VS; Pokrovsky VS; Pokrovskaya MV; Aleksandrova SS; Sokolov NN
Biomed Khim; 2017 Jan; 63(1):13-26. PubMed ID: 28251947
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.
Gan Y; Lu J; Yeung BZ; Cottage CT; Wientjes MG; Au JL
AAPS J; 2015 Jan; 17(1):268-76. PubMed ID: 25425294
[TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
[TBL] [Abstract][Full Text] [Related]
11. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Jafri MA; Ansari SA; Alqahtani MH; Shay JW
Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant intracellular Rhodospirillum rubrum L-asparaginase with low L-glutaminase activity and antiproliferative effect].
Pokrovskaia MV; Pokrovskiĭ VS; Aleksandrova SS; Anisimova NIu; Adrianov RM; Treshchalina EM; Ponomarev GV; Sokolov NN
Biomed Khim; 2013; 59(2):192-208. PubMed ID: 23789346
[TBL] [Abstract][Full Text] [Related]
13. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.
Qi Z; Mi R
Cancer Gene Ther; 2016 Jan; 23(1):36-42. PubMed ID: 26742579
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth.
Cassar L; Li H; Pinto AR; Nicholls C; Bayne S; Liu JP
Cancer Res; 2008 Nov; 68(22):9157-66. PubMed ID: 19010887
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
[TBL] [Abstract][Full Text] [Related]
17. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
[TBL] [Abstract][Full Text] [Related]
18. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
[TBL] [Abstract][Full Text] [Related]
19. Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms.
Uziel O; Beery E; Dronichev V; Samocha K; Gryaznov S; Weiss L; Slavin S; Kushnir M; Nordenberg Y; Rabinowitz C; Rinkevich B; Zehavi T; Lahav M
PLoS One; 2010 Feb; 5(2):e9132. PubMed ID: 20161752
[TBL] [Abstract][Full Text] [Related]
20. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
